These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. TRPV4 regulates the integrity of the blood-cerebrospinal fluid barrier and modulates transepithelial protein transport. Narita K; Sasamoto S; Koizumi S; Okazaki S; Nakamura H; Inoue T; Takeda S FASEB J; 2015 Jun; 29(6):2247-59. PubMed ID: 25681460 [TBL] [Abstract][Full Text] [Related]
8. Characterization of transient receptor potential vanilloid channel 4 (TRPV4) in human corneal endothelial cells. Mergler S; Valtink M; Taetz K; Sahlmüller M; Fels G; Reinach PS; Engelmann K; Pleyer U Exp Eye Res; 2011 Nov; 93(5):710-9. PubMed ID: 21996372 [TBL] [Abstract][Full Text] [Related]
9. The effect of transient receptor potential vanilloid 4 on the intestinal epithelial barrier and human colonic cells was affected by tyrosine-phosphorylated claudin-7. Huang YY; Li J; Zhang HR; Bai SW; Yang HY; Shen B; Du J; Xia XM Biomed Pharmacother; 2020 Feb; 122():109697. PubMed ID: 31918271 [TBL] [Abstract][Full Text] [Related]
10. Delayed disruption of barrier function in cultured human corneal epithelial cells induced by tumor necrosis factor-alpha in a manner dependent on NF-kappaB. Kimura K; Teranishi S; Fukuda K; Kawamoto K; Nishida T Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):565-71. PubMed ID: 18235000 [TBL] [Abstract][Full Text] [Related]
12. IQGAP1 controls tight junction formation through differential regulation of claudin recruitment. Tanos BE; Perez Bay AE; Salvarezza S; Vivanco I; Mellinghoff I; Osman M; Sacks DB; Rodriguez-Boulan E J Cell Sci; 2015 Mar; 128(5):853-62. PubMed ID: 25588839 [TBL] [Abstract][Full Text] [Related]
13. Sec61β regulates barrier functions of tight junction through expression of claudin-4 in Madin-Darby canine kidney cells. Washiyama M; Koizumi N; Fujii M; Watanabe Y Biol Pharm Bull; 2014; 37(6):979-86. PubMed ID: 24882410 [TBL] [Abstract][Full Text] [Related]
14. RCE1 corneal epithelial cell line: its variability on phenotype expression and differential response to growth factors. Tamariz E; Hernandez-Quintero M; Sánchez-Guzman E; Arguello C; Castro-Muñozledo F Arch Med Res; 2007 Feb; 38(2):176-84. PubMed ID: 17227726 [TBL] [Abstract][Full Text] [Related]
15. Protection of human corneal epithelial cells from hypoxia-induced disruption of barrier function by hepatocyte growth factor. Kimura K; Teranishi S; Kawamoto K; Nishida T Exp Eye Res; 2010 Feb; 90(2):337-43. PubMed ID: 19944686 [TBL] [Abstract][Full Text] [Related]
16. Role of transient receptor potential vanilloid 4 activation in indomethacin-induced intestinal damage. Yamawaki H; Mihara H; Suzuki N; Nishizono H; Uchida K; Watanabe S; Tominaga M; Sugiyama T Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(1):G33-40. PubMed ID: 24789205 [TBL] [Abstract][Full Text] [Related]
17. Formation and barrier function of tight junctions in human ovarian surface epithelium. Zhu Y; Maric J; Nilsson M; Brännström M; Janson PO; Sundfeldt K Biol Reprod; 2004 Jul; 71(1):53-9. PubMed ID: 14973266 [TBL] [Abstract][Full Text] [Related]
19. The effect of serine phosphorylated claudin-7 on the epithelial barrier and the modulation by transient receptor potential vanilloid 4 in human colonic cells. Huang YY; Wang ZK; Li J; Bai SW; Shen B; Du J; Xia XM; Wang FY Biomed Pharmacother; 2018 Dec; 108():540-546. PubMed ID: 30243087 [TBL] [Abstract][Full Text] [Related]
20. Culture model of human corneal epithelium for prediction of ocular drug absorption. Toropainen E; Ranta VP; Talvitie A; Suhonen P; Urtti A Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2942-8. PubMed ID: 11687540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]